Combination treatment with troglitazone, an insulin action enhancer, and pravastatin, an inhibitor of HMG-CoA reductase, shows a synergistic effect on atherosclerosis of WHHL rabbits - Shiomi, M; Ito, T; Tsukada, T (Atherosclerosis, 1999)
et al